TALPHERA, INC. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- TALPHERA, INC. stock issued during period, value, new issues for the quarter ending 2024-03-31 was $5.88M.
- TALPHERA, INC. stock issued during period, value, new issues for the quarter ending 2022-09-30 was $192.00K.
- TALPHERA, INC. stock issued during period, value, new issues for the quarter ending 2021-03-31 was $36.36M, a 4537.76% increase year-over-year.
- TALPHERA, INC. stock issued during period, value, new issues for the quarter ending 2020-09-30 was $9.95M, a 707.06% increase year-over-year.
- TALPHERA, INC. stock issued during period, value, new issues for fiscal 2022 was $790.00K.
- TALPHERA, INC. stock issued during period, value, new issues for fiscal 2020 was $21.34M, a 1630.49% increase from fiscal 2019.
- TALPHERA, INC. stock issued during period, value, new issues for fiscal 2019 was $1.23M, a 98.49% decline from fiscal 2018.
- TALPHERA, INC. stock issued during period, value, new issues for fiscal 2018 was $81.53M, a 419.47% increase from fiscal 2017.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2024-03-31 | $5.88M 10-Q · filed 2025-08-14 | |
| 2022-12-31 | $790.00K 10-K · filed 2024-03-06 | |
| 2022-09-30 | $192.00K 10-Q · filed 2023-11-14 | |
| 2021-12-31 | $44.72M 8-K · filed 2023-08-01 | |
| 2021-03-31 | $36.36M 10-Q · filed 2022-11-14 | |
| 2020-12-31 | $21.34M 10-K · filed 2022-03-10 | |
| 2020-09-30 | $9.95M 10-Q · filed 2021-11-15 | |
| 2020-06-30 | $665.00K 10-Q · filed 2021-11-15 | |
| 2020-03-31 | $784.00K 10-Q · filed 2021-11-15 | |
| 2019-12-31 | $1.23M 10-K · filed 2021-03-15 | |
| 2019-09-30 | $1.23M 10-Q · filed 2020-11-05 | |
| 2018-12-31 | $81.53M 10-K · filed 2021-03-15 | |
| 2018-09-30 | $21.67M 10-Q · filed 2019-11-07 | |
| 2018-06-30 | $7.41M 10-Q · filed 2019-11-07 | |
| 2017-12-31 | $15.69M 10-K · filed 2020-03-16 | |
| 2011-12-31 | $34.94M 10-K · filed 2014-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |